Switching from pathogenetic treatment with α-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients

Journal of Diabetes and its Complications

Volumn 23, Issue 3, 2009, Pages 174-177

  Ruessmann, Heinz Jürgen ^a  

^a Heinz Jürgen Ruessmann ^*  (Germany)

Author keywords

lipoic acid; Diabetic neuropathy

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; FENTANYL; GABAPENTIN; MORPHINE; PREGABALIN; THIOCTIC ACID; TRAMADOL;

ADULT; ADVERSE OUTCOME; AGED; ANALGESIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DIZZINESS; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FALL RISK; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; NEUROPATHIC PAIN; OUTPATIENT; PARESTHESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTIGO;

AGED; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DIABETIC NEUROPATHIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; OUTPATIENTS; RETROSPECTIVE STUDIES; THIOCTIC ACID;

EID: 65249103372     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.02.002     Document Type: Article

References (20)

1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., and Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. Journal of the American Medical Association 280 (1998) 1831-1836
2. Benbow S.J., Chan A.W., Bowsher D., MacFarlane I.A., and Williams G. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Medicine 11 (1993) 17-21
3. Berger A., Dukes E., Edelsberg J., Stacey B., and Oster G. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clinical Journal of Pain 23 3 (2007) 251-258
4. Boulton A.J.M., Scarpello J.H.B., Armstrong W.D., and Ward J.D. The natural history of painful diabetic neuropathy - a 4-year study. Postgraduate Medical Journal 59 (1983) 556-559
5. Cohen H.W., Gibson G., and Alderman M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. American Journal of Medicine 108 (2000) 2-8
6. Daousi C., Benbow S.J., Woodward A., and MacFarlane I.A. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabetic Medicine 23 (2006) 1021-1024
7. Davies M., Brophy S., Williams R., and Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 29 (2006) 1518-1522
8. Flather M., Delahunty N., and Collinson J. Generalizing results of randomized trials to clinical practice: Reliability and cautions. Clinical Trials 3 (2006) 508-512
9. Galer B.S., Gianas A., and Jensen M.P. Painful diabetic neuropathy: Epidemiology, pain description, and quality of life. Diabetes Research and Clinical Practice 47 (2000) 123-128
10. Giannopoulos S., Kosmidou M., Sarmas I., Markoula S., Pelidou S.H., Lagos G., and Kyritsis A.P. Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy. Clinical Journal of Pain 23 (2007) 267-269
11. Tarride J.E., Gordon A., Vera-Llonch M., Dukes E., and Rousseau C. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective. Clinical Therapeutics 28 (2006) 1922-1934
12. Vera-Llonch M., Dukes E., Delea T.E., Wang S.T., Oster G., and Neuropathic Pain Outcomes Modeling Working Group. Treatment of peripheral neuropathic pain: A simulation model. European Journal of Pain 10 (2006) 279-285
13. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 25 4 (2004) 612-628
14. Wu E.Q., Birnbaum H.G., Mareva M.N., Le T.K., Robinson R.L., Rosen A., and Gelwicks S. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain. Journal of Pain 7 (2006) 399-407
15. Young R.J., Ewing D.J., and Clarke B.F. Chronic and remitting painful diabetic neuropathy. Diabetes Care 11 (1988) 34-40
16. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.D.R., and Sönksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
17. Ziegler D. Thioctic acid for patients with symptomatic diabetic neuropathy. A critical review. Treatments in Endocrinology 3 (2004) 1-17
18. Ziegler D., Ametov A., Barinov A., Dyck P.J., Gurieva I., Low P.A., Munzel U., Yakhno N., Raz I., Novosadova M., Maus J., and Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 29 (2006) 2365-2370
19. Ziegler D., Low P.A., Boulton A.J.M., Vinik A.I., Freeman R., Samigullin R., Tritschler H., Munzel U., Maus J., Schuette K., and Dyck P.J. Effect of 4-year antioxidant treatment with a-lipoic acid in diabetic polyneuropathy: The NATHAN 1 trial. Diabetes 56 suppl (2007) (abstract, in press)
20. Ziegler D., Nowak H., Kempler P., Vargha P., and Low P.A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant a-lipoic acid: A meta-analysis. Diabetic Medicine 21 (2004) 114-121